CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cellcura ASA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cellcura ASA
Unionsgata 18
Phone: +47 22947700p:+47 22947700 Skien, 3732  Norway Ticker: CELLCELL
As of 2/17/2015, Dag Dvergsten AS owns a 90.10% stake in the Company.
This company is no longer actively traded on any major stock exchange.
Business Summary
Cellcura ASA is a Norway-based company engaged in the development and sales of cell technology. It provides equipment and products for use in Assisted Reproductive Technology (ART) and Stem Cell Research. Its current offering comprises Protein Free Media (PFM-11), a range of culture media products that eliminates risks of transmission of blood borne diseases, and integrated workstations, consisting of Egg recovery (ERM), ICSI and Utility modules, that secures a safe, ergonomic and controlled environment for performing cellular treatment. CELLCURA ASA partners with WiCell, an organization specializing in the area of human embryonic stem (hES) cell research; Zeiss, a manufacturer of optics and microscopes for industrial, biological and medical applications, and Eppendorf, a German manufacturer of laboratory instruments and consumables for the life sciences. The Company operates two subsidiaries CellCura, Inc. in the United States and IHMedical A/S in Denmark.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201412/31/2013Yes----

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Dag O.Dvergsten 7/1/2005 7/1/2005
Interim Chief Executive Officer ToreViana-Ronningen 1/20/2014 1/20/2014
Chief Executive Officer of CellCura Inc LesleyHutchins
8 additional Officers and Directors records available in full report.

Business Names
Business Name
CELL
CellCura, Inc.
IHMedical A/S

General Information
Outstanding Shares: 6,520,500 (As of 9/30/2014)
Shareholders: 2
Stock Exchange: OSL
Fax Number: +47 35122619


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023